SureTrader Advertisement PRTC
Home > Boards > US Listed > Biotechs >

Acadia Pharmaceuticals Inc. (ACAD)

ACAD RSS Feed
Add ACAD Price Alert      Hide Sticky   Hide Intro
Moderator: 2014shelby
Search This Board:
Last Post: 5/28/2016 7:54:06 PM - Followers: 137 - Board type: Free - Posts Today: 0

http://www.acadia-pharm.com/

http://finance.yahoo.com/q/ks?s=ACAD

ACADIA Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of small molecule drugs for the treatment of central nervous system disorders. Its developing products include Pimavanserin for the treatment of Parkinson's disease psychosis in Phase III trials; Pimavanserin as a co-therapy for schizophrenia in Phase II trials; ACP-104 for the treatment of schizophrenia in Phase IIb clinical trials; Pimavanserin for sleep maintenance insomnia in Phase II trials; AGN-XX and AGN-YY for neuropathic pain in Phase II trials; and AC-262271 for glaucoma in Phase I trials. The company's developing pipeline also consists of ACP-105 for endocrine indications in IND-track development stage; ACP-106 for neuropsychiatry and sleep indications in IND-track development stage; Serotonin program for neuropsychiatry and sleep indications in preclinical stage; pro-cognitive antipsychotic (PCAP) program for schizophrenia in preclinical stage; Muscarinic program for neuropsychiatry and other indications in preclinical stage; and Cannabinoid CB1 program for obesity in preclinical stage. The company has collaboration agreements with Allergan, Inc. to discover, develop, and commercialize new therapeutics for ophthalmic indications, selective muscarinic drugs for the treatment of glaucoma, and new therapeutics for neuropathic pain. ACADIA Pharmaceuticals, formerly known as Receptor Technologies, Inc., was founded in 1993. The company is headquartered in San Diego, California.



 

  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
ACAD
Current Price
Volume:
Bid Ask Day's Range
SureTrader
ACAD News: Confidential Treatment Order (ct Order) 05/19/2016 03:01:50 PM
ACAD News: Quarterly Report (10-q) 05/05/2016 04:55:23 PM
ACAD News: Current Report Filing (8-k) 05/05/2016 04:18:47 PM
ACAD News: ACADIA Pharmaceuticals to Present at the Bank of America Merrill Lynch 2016 Health Care Conference on May 11, 2016 05/04/2016 09:01:00 AM
ACAD News: Current Report Filing (8-k) 05/03/2016 04:43:54 PM
PostSubject
#2150   wish i could! keep me posted harry crumb 05/28/16 07:54:06 PM
#2149   Ok then what do you think ACAD BO 2014shelby 05/27/16 04:42:45 AM
#2148   The shareholders meeting may yield something interesting. EFHutton7 05/27/16 12:17:50 AM
#2147   40 next level. i am expecting this within harry crumb 05/26/16 10:35:47 PM
#2146   moving up as mentioned. $$$ harry crumb 05/24/16 11:25:05 AM
#2145   Appears as if the cup and handle is EFHutton7 05/17/16 01:27:45 PM
#2144   strong! harry crumb 05/17/16 12:17:07 PM
#2143   How high it keeps going up? Patrickwan1 05/17/16 11:44:25 AM
#2142   Agreed EFHutton7 05/12/16 08:43:57 PM
#2141   all the professional analysts i spoke with are harry crumb 05/12/16 09:11:02 AM
#2140   I'm surprised at some of the stuff SA EFHutton7 05/11/16 08:29:50 PM
#2139   yeah really, did u read it? omg its harry crumb 05/11/16 12:48:49 PM
#2138   Haha or maybe he read my post on EFHutton7 05/11/16 11:55:47 AM
#2137   sa hit piece has no merit but ones harry crumb 05/11/16 09:51:06 AM
#2136   It would be smarter if management waited until EFHutton7 05/11/16 01:35:52 AM
#2135   smart move. the offer will be 50+ thats harry crumb 05/10/16 12:48:28 PM
#2134   I think with the recent article re BIIB EFHutton7 05/09/16 06:22:58 PM
#2133   long an strong here on acad, 50+ will harry crumb 05/09/16 12:13:55 PM
#2132   would love for this to dip back down jloerke 05/09/16 09:12:11 AM
#2131   Potential BO candidates for ACAD: http://realmoney.thestreet.com/articles/05/07 2014shelby 05/08/16 09:21:17 AM
#2130   not for u! get lost harry crumb 05/06/16 11:38:24 PM
#2129   Appears the market shrugged off the pricing info. EFHutton7 05/06/16 10:41:09 AM
#2128   Watch and try and learn. klouis 05/06/16 04:15:24 AM
#2127   Watch and learn. klouis 05/06/16 04:13:51 AM
#2126   my take, if u own enough shares, congrats harry crumb 05/05/16 11:41:13 PM
#2125   your crazy! harry crumb 05/05/16 11:37:50 PM
#2124   Game changer. EFHutton7 05/05/16 11:10:10 PM
#2123   Look AH..... Rymankoly 05/05/16 06:31:03 PM
#2122   Baker selling converted shares?? sorkin 05/05/16 01:52:05 PM
#2121   Agree but probably at a price lower than EFHutton7 05/05/16 10:22:42 AM
#2120   Yep masterbug1 05/05/16 09:38:24 AM
#2119   The biggest candidate for a buyout in the akocaman 05/05/16 09:01:08 AM
#2118   They and Bakers deserve this and more after EFHutton7 05/04/16 07:34:53 PM
#2117   Ugly! sorkin 05/04/16 06:40:52 PM
#2116   Don't they have another cc today? EFHutton7 05/04/16 05:12:11 PM
#2115   I know several in the sales force, told Tanis2476 05/04/16 05:02:27 PM
#2114   No I don't think a buyout. EFHutton7 05/04/16 04:59:46 PM
#2113   I agree it's going back down to below Tanis2476 05/04/16 04:50:07 PM
#2112   I was long then short then long then EFHutton7 05/04/16 04:46:56 PM
#2111   A short time ago you said you went north40000 05/04/16 02:43:29 PM
#2110   We don't need any help. EFHutton7 05/04/16 02:18:23 PM
#2109   Stop trying to fear monger to help your itsthebox1 05/04/16 01:55:58 PM
#2108   How much time do you think the Baker 2014shelby 05/04/16 01:42:05 PM
#2107   It will never see 60 or its all EFHutton7 05/04/16 12:02:08 PM
#2106   Extraneous factors are of course helping to bring EFHutton7 05/04/16 11:55:07 AM
#2105   Still looking? Jumpinjackas 05/04/16 11:36:42 AM
#2104   Buyout won't come until they get additional indications. Tanis2476 05/04/16 10:50:35 AM
#2103   How would you price in today's market and north40000 05/04/16 10:35:58 AM
#2102   If longs are lucky! They wait too EFHutton7 05/04/16 12:37:10 AM
#2101   I dont think the Bakers had any idea EFHutton7 05/04/16 12:34:59 AM
PostSubject